Prophylactic Use of Itraconazole for the Prevention of Invasive Pulmonary Aspergillosis in High Risk Neutropenic Patients

References

• Goodrich J. M., Reed E. C., Mori M., Fischer L. D., Skerrett S., Dandliker P. S., Klis B., Counts G. W., Meyers J. D. Clinical features and analysis of risk factors for invasive Candidal infection after marrow transplantation. J. Infect. Dis. 1991; 164: 731
   PubMed Web of Science ®Google Scholar
• Guiot H. F. L., Fibbe W. E., Van'T Wout J. W. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin. Infect. Dis. 1994; 18: 525
   PubMed Web of Science ®Google Scholar
• Degregorio M. W., Lee W. M. F., Linker C. A., Jacobs R. A., Ries C. A. Fungal infections in patients with acute leukemia. Am. J. Med. 1982; 73: 543
   PubMed Web of Science ®Google Scholar
• Weinberger M., Elattar I., Marshall D., Steinberg S. M., Redner R. L., Young N. S., Pizzo P. A. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine 1992; 71: 24
   PubMed Web of Science ®Google Scholar
• Saugier-Veber P., Devergie A., Sulahian A., Ribaud P., Traore F., Bourdeau-Esperou H., Gluckman E., Derouin F. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant 1993; 12: 121
   PubMed Web of Science ®Google Scholar
• Morrison V. A., Haake R. J., Weidorf D. J. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 1994; 96: 497
   PubMed Web of Science ®Google Scholar
• Weems J. J., Davis B. J., Tablan O. C., Kaufman L., Martone W. J. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect. control. 1987; 8: 171
   Google Scholar
• Beyer J., Schwartz S., Heinemann V., Siegert W. Strategies in prevention of invasive aspergillosis in immunosuppressed or neutropenic patients. Antimicrob. Agents. Chemother. 1994; 38: 911
   PubMed Web of Science ®Google Scholar
• Uzun O., Anaissie J. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 1995; 86: 2063
   PubMed Web of Science ®Google Scholar
• Jeffery G. M., Beard M. E. J., Ikram R. B., Chua J., Allen J. R., Heaton D. C., Hart D. N. J., Schousboe M. I. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am. J. Med. 1991; 90: 685
   PubMed Web of Science ®Google Scholar
• Meunier-Carpentier F., Snoeck R., Gerain J., Muller C., Klastersky J. Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. N. Engl. J. Med. 1984; 311: 1056
   PubMed Web of Science ®Google Scholar
• Rousey S. R., Russler S., Gottlieb M., Robert C. Low-Dose amphotericin B-prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am. J. Med. 1991; 91: 484
   PubMed Web of Science ®Google Scholar
• Riley D. K., Pavia A. T., Beatty P. G., Petersen F. B., Spruance J. L., Stokes R., Evans T. G. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am. J. Med. 1994; 97: 509
   PubMed Web of Science ®Google Scholar
• O'Donnell M. R., Schmidt G. M., Tegtmeier B. R., Faucett C., Fahey J. L., Ito J., Nademanee A., Niland J., Parker P., Smith E. P., Snyder D. S., Stein A. S., Blume K. G., Forman S. J. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J. Clin. Oncol. 1994; 12: 827
   PubMed Web of Science ®Google Scholar
• Vreugdenhil G., Van Duke B. J., Donnelly J. P., Novokova I. R. O., Raemaekers J. M. M., Hookgkamp-Korstanje M. A. A., Roster M., De Pauw B. E. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leukemia Lymphoma 1993; 11: 353
   PubMed Web of Science ®Google Scholar
• Tricot G., Joosten E., Boogaerts M. A., Vande Pitte J., Cauwenbergh G. Retoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infect. Dis. 1987; 9(Suppll)94
   Google Scholar
• Prentice A. G., Bradford G. R. Prophylaxis of fungal infections with itraconazole during remission-induction therapy. Mycoses. 1989; 32: 96
   PubMed Web of Science ®Google Scholar
• Thunnissen P. L. M., Sizoo W., Hendriks W. D. H. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Neth. J. Med. 1991; 39: 84
   PubMed Web of Science ®Google Scholar
• Hoelzer D., Thiel E., Ludwig W. D., Loftier H. I. The German multicentre trials for treatment of acute lymphoblastic leukaemia in adults. Leukemia 1992; 6: 175
   PubMedGoogle Scholar
• De Beule K., De Doncker P., Cauwenbergh G., Roster M., Legendre R., Blatchford N., Daunas J., Chwetzoff E. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study 1982–1987. Mycoses. 1988; 31: 476
   PubMed Web of Science ®Google Scholar
• Denning D. W., Tucker R. M., Hanson L. H., Stevens D. A. Treatment of invasive aspergillosis with Itraconazole. Am. J. Med. 1989; 86: 791
   PubMed Web of Science ®Google Scholar
• Denning D. W., Lee J. Y., Hosteller J. S., Pappas P., Rauffman C. A., Dewsnup D. H., Galgiani J. N., Graybill J. R., Sugar A. M., Catanzaro A., Gallis H., Perfect J. R., Dockery B., Dismukes W. E., Stevens D. A. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am. J. Med. 1994; 97: 135
   PubMed Web of Science ®Google Scholar
• Van'Twout J. W., Novakova J., Verhagen C. A. H., Fibbe W. E., De Paw B. E., Van Der Meer J. W. M. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J. Infection. 1991; 22: 45
   PubMed Web of Science ®Google Scholar
• Warren R. E. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J. Antimicrob. Chemother. 1989; 32: 5
   Google Scholar
• Boogaerts M. A., Verhoef G. E., Zachee P., Demuynck H. I. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses. 1989; 32, Suppl 1, 103.
   Web of Science ®Google Scholar
• Goodman J. L., Winston D. J., Greenfield R. A., Chandrasekar P. H., Fow B., Kaizer H., Schadduck R. R., Shea T. C., Stiff P., Friedman D. J., Powderly W. G., Silber J. L., Horowitz H., Lichtin A., Wolff S. N., Mangan R. F., Silver S. M., Weisdorf D., Ho W. G., Gilbert G., Buell D. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 1992; 326: 315
   Web of Science ®Google Scholar
• Winston D. J., Chandrasekar P. H., Lazarus H. M., Goodman J. L., Silber J. L., Horowitz H., Shadduck R. R., Rosenfeld C. S., Ho W. G., Islam M. Z., Buell D. N. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Ann Intern Med. 1993; 118: 495–503
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Rarp J. E., Saral R. Increase of Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 1991; 325: 1274
   PubMed Web of Science ®Google Scholar
• Grant S. M., Clissold S. P. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficila and systemic mycoses. Drugs 1989; 37: 310
   PubMed Web of Science ®Google Scholar